Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol

被引：0
|
作者：
Gonzalez Leal, A. [1 ]
Sanchez Vega, J. D. [1 ]
Antonana Ugalde, S. [1 ]
Arteagoitia Bolumburu, A. [1 ]
Alvarez-Garcia, J. [1 ]
Del Prado, S. [1 ]
Cordero, D. [1 ]
Jimenez-Blanco, M. [1 ]
Castillo, M. [1 ]
Gonzalez Ferrer, E. [1 ]
Zamorano, J. L. [1 ]
Alonso Salinas, G. L. [2 ]
机构：
[1] Hosp Ramon & Cajal, Cardiol Dept, Madrid, Spain
[2] Hosp Complex Navarra, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [31] Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation
    JoEllyn M. Abraham
    Stuart J. Connolly
    Heart Failure Reviews, 2014, 19 : 305 - 313
  • [32] Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation
    Abraham, JoEllyn M.
    Connolly, Stuart J.
    HEART FAILURE REVIEWS, 2014, 19 (03) : 305 - 313
  • [33] Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation
    Pastori, Daniele
    Pignatelli, Pasquale
    Saliola, Mirella
    Carnevale, Roberto
    Vicario, Tommasa
    Del Ben, Maria
    Cangemi, Roberto
    Barilla, Francesco
    Lip, Gregory Y. H.
    Violi, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 513 - 516
  • [34] Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis
    Reyes, Jorge L.
    Herzog, Charles A.
    Yan, Heng
    Roetker, Nicholas S.
    Wetmore, James B.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [35] Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation
    Iten, Vasco
    Herber, Elena
    Coslovsky, Michael
    Hennings, Elisa
    Paladini, Rebecca E.
    Reichlin, Tobias
    Rodondi, Nicolas
    Mueller, Andreas S.
    Stauber, Annina
    Beer, Juerg H.
    Brenner, Roman
    Conte, Giulio
    Kobza, Richard
    Di Valentino, Marcello
    Bedoya, Patricia Chocano
    Moradi, Freschteh
    Sinnecker, Tim
    Bonati, Leo H.
    Kuehne, Michael
    Osswald, Stefan
    Conen, David
    Aeschbacher, Stefanie
    Zuern, Christine S.
    BMC MEDICINE, 2024, 22 (01):
  • [36] Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation
    Yoshihisa, Akiomi
    Sato, Yu
    Sato, Takamasa
    Suzuki, Satoshi
    Oikawa, Masayoshi
    Takeishi, Yasuchika
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [37] Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation
    Akiomi Yoshihisa
    Yu Sato
    Takamasa Sato
    Satoshi Suzuki
    Masayoshi Oikawa
    Yasuchika Takeishi
    BMC Cardiovascular Disorders, 18
  • [38] Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation
    Correale, Michele
    Leopizzi, Alessandra
    Mallardi, Adriana
    Ranieri, Alessandro
    Suriano, Miriam Pia
    D'Alessandro, Damiano
    Tricarico, Lucia
    Mazzeo, Pietro
    Tucci, Salvatore
    Pastore, Giuseppe
    Maulucci, Guglielmo
    Di Biase, Matteo
    Brunetti, Natale Daniele
    THROMBOSIS RESEARCH, 2020, 195 : 16 - 20
  • [39] Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation
    Marin, Francisco
    Anguita-Sanchez, Manuel
    Sanmartin, Marcelo
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (01) : 67 - 77
  • [40] A systematic review of clinicians' views and experiences of direct-acting oral anticoagulants in the management of nonvalvular atrial fibrillation
    Generalova, Daria
    Cunningham, Scott
    Leslie, Stephen J.
    Rushworth, Gordon F.
    McIver, Laura
    Stewart, Derek
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (12) : 2692 - 2703
12345